The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient-derived organoid (PDO), a new personalized therapy selection tool for prompt clinical decision making in metastatic gastrointestinal (mGI) cancer patients.
 
Hao Xie
No Relationships to Disclose
 
Tara L Hogenson
No Relationships to Disclose
 
Isaac P Horn
No Relationships to Disclose
 
Luciana Almada
No Relationships to Disclose
 
David Marks
Stock and Other Ownership Interests - Cardinal Health (I); Perrigo (I); Prothena (I); WebMD
 
Amanda Koenig
No Relationships to Disclose
 
Ezequiel Tolosa
No Relationships to Disclose
 
Michael T. Barrett
No Relationships to Disclose
 
James H Boyum
No Relationships to Disclose
 
Amit Mahipal
Research Funding - Astellas Scientific and Medical Affairs Inc (Inst); Karyopharm Therapeutics (Inst); Novartis (Inst)
 
Joleen Marie Hubbard
Consulting or Advisory Role - Genentech/Roche (Inst)
Research Funding - Bayer (Inst); Boston Biomedical (Inst); eFFECTOR Therapeutics (Inst); Merck (Inst); Senhwa Biosciences (Inst); Taiho Pharmaceutical (Inst); Treos Bio (Inst)
 
Temperance J Scheffler Hanson
No Relationships to Disclose
 
Jun Yin
No Relationships to Disclose
 
Gloria M. Petersen
No Relationships to Disclose
 
Alexander Revzin
No Relationships to Disclose
 
Daniel D. Billadeau
No Relationships to Disclose
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bayer; Bayer (Inst); Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Celgene; Celgene (Inst); Genentech/Roche; Glenmark; Immuneering; Imugene; Incyte (Inst); Ipsen (Inst); Lilly; Lilly (Inst); Merck (Inst); NCCN; Pfizer; Regeneron; Roche/Genentech (Inst); Sirtex Medical; Taiho Pharmaceutical
Research Funding - NCCN; NCI; Oncolytics
Other Relationship - ARMO BioSciences; Exelixis; Exelixis; Merck; Polaris; Sillajen
 
Alex A. Adjei
Research Funding - Bayer Schering Pharma (Inst); Bayer Schering Pharma (Inst); Bayer Schering Pharma (Inst); Bayer Schering Pharma (Inst)
 
Wen Wee Ma
Research Funding - Athenex (Inst); Merrimack (Inst)
 
Martin Fernandez-Zapico
No Relationships to Disclose